← Evidence map

ArticleClinical and experimental immunology2026

Selinexor potentiates NK cell activation against multiple myeloma.

Daniel T Harding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42798230